April 2012 | MD Anderson Cancer Center Skip to Content
Top

BY Laura Sussman

More than one third of patients with invasive cancer are undertreated for their pain, with minorities twice as likely to not receive appropriate medication, according to new MD Anderson-led research.

The study published in Journal of Clinical Oncology, is the largest prospective evaluation of cancer pain and related symptoms ever conducted in an outpatient setting.

Almost 20 years ago, Charles Cleeland, Ph.D., professor...

BY Scott Merville

An antibody created at MD Anderson blocks the life-threatening gastrointestinal damage caused by high levels of radiation - so far in mice...

BY Leslie Loddeke

Patrick Hwu, M.D., head of MD Anderson's Department of Melanoma Medical Oncology, presented evidence supporting the combination of BRAF inhibitors...

BY Scott Merville

A creative plan to identify new drugs to prevent cancer has earned an MD Anderson scientist a prominent national award to support her research.

Guang Peng, M.D., Ph.D., an assistant professor in the Department of Clinical Cancer Prevention, is the winner of the Fifth Annual Landon Foundation-AACR INNOVATOR Award for Cancer Prevention Research.

The American Association for Cancer Research will honor Peng and the Landon award...

BY Scott Merville

A vaccine that targets the HER2 protein has triggered immune responses among patients in a phase II clinical trial to prevent recurrence of...